Serina Therapeutics (SER) news

Trading halt: Aztr (AMEX) - Regulatory concern

On October 13, 2026, trading for Aztr (AMEX) was temporarily suspended amid regulatory concerns, according to reports. While no official statement has been issued by the New York Stock Exchange, the halt has raised questions among investors about the company’s compliance status and operational…

Adani Green Generation capacity 20.8 GW at end-Sept, +24% y/y

Adani Green Energy Ltd (AGEL) has reported a significant increase in its renewable energy generation capacity, reaching 20.8 gigawatts (GW) as of the end of September 2026, representing a 24% year-over-year growth . This expansion underscores the company’s ongoing commitment to scaling India’s…

Serina Therapeutics - Expects to report topline data from the single-ascending-dose portion of the study in first half of 2027

Serina Therapeutics, Inc. (NYSE American: SER), a clinical-stage biotechnology company, has completed enrollment and dosing in Cohort 1 of its Phase 1b registrational study of SER-252, an investigational apomorphine therapy for advanced Parkinson’s disease. The milestone was achieved ahead of the…

Serina Therapeutics Inc: Reports cohort 1 observations from ser-252 registrational study in advanced Parkinson’s disease and advances to cohort 2

Serina Therapeutics Inc. (NYSE American: SER) has completed enrollment and dosing in Cohort 1 of its Phase 1b registrational clinical trial evaluating SER-252, an investigational apomorphine therapy for advanced Parkinson’s disease. All eight patients in Cohort 1 were enrolled and dosed across…

Serina Therapeutics - May sell up to $25 mln of common stock to Roth principal investments - SEC filing